| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GSE228371
|
Morgan Zenner
|
Sep 22, 2023
|
||||||
| GSM7119810 |
prostate cancer patient pre-treatment serum EV, ENACTEV4004
|
RNA | 1 |
|
Morgan Zenner | Sep 22, 2023 | |||
| GSM7119811 |
prostate cancer patient pre-treatment serum EV, ENACTEV4005
|
RNA | 1 |
|
Morgan Zenner | Sep 22, 2023 | |||
| GSM7119812 |
prostate cancer patient pre-treatment serum EV, ENACTEV4007
|
RNA | 1 |
|
Morgan Zenner | Sep 22, 2023 | |||
| GSM7119813 |
prostate cancer patient pre-treatment serum EV, ENACTEV4009
|
RNA | 1 |
|
Morgan Zenner | Sep 22, 2023 | |||
| GSM7119814 |
prostate cancer patient pre-treatment serum EV, ENACTEV4011
|
RNA | 1 |
|
Morgan Zenner | Sep 22, 2023 | |||
| GSM7119815 |
prostate cancer patient pre-treatment serum EV, ENACTEV4013
|
RNA | 1 |
|
Morgan Zenner | Sep 22, 2023 | |||
| GSM7119816 |
prostate cancer patient pre-treatment serum EV, ENACTEV4014
|
RNA | 1 |
|
Morgan Zenner | Sep 22, 2023 | |||
| GSM7119817 |
prostate cancer patient pre-treatment serum EV, ENACTEV4016
|
RNA | 1 |
|
Morgan Zenner | Sep 22, 2023 | |||
| GSM7119818 |
prostate cancer patient pre-treatment serum EV, ENACTEV5021
|
RNA | 1 |
|
Morgan Zenner | Sep 22, 2023 | |||
| GSM7119819 |
prostate cancer patient pre-treatment serum EV, ENACTEV5031
|
RNA | 1 |
|
Morgan Zenner | Sep 22, 2023 | |||
| GSM7119820 |
prostate cancer patient pre-treatment serum EV, ENACTEV5034
|
RNA | 1 |
|
Morgan Zenner | Sep 22, 2023 | |||
| GSM7119821 |
prostate cancer patient pre-treatment serum EV, ENACTEV6007
|
RNA | 1 |
|
Morgan Zenner | Sep 22, 2023 |
